Apr 01, 2021 8:28am EDT BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
Feb 26, 2021 10:32am EST EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Feb 22, 2021 8:38am EST New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy
Feb 18, 2021 4:05pm EST OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
Feb 03, 2021 9:01am EST OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
Jan 28, 2021 8:00am EST New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency
Jan 26, 2021 8:30am EST OPKO Health’s GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
Jan 26, 2021 8:00am EST OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
Jan 13, 2021 3:40pm EST OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access